A Vaccine (VSV-hIFNβ-NIS) With or Without Cyclophosphamide and Combinations of Ipilimumab, Nivolumab, and Cemiplimab in Treating Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia or Lymphoma
Mayo Clinic
Mayo Clinic
Barbara Ann Karmanos Cancer Institute
City of Hope Medical Center
Northwestern University
Roswell Park Cancer Institute
Barbara Ann Karmanos Cancer Institute
M.D. Anderson Cancer Center
Jonsson Comprehensive Cancer Center
Case Comprehensive Cancer Center
Mayo Clinic
Canadian Cancer Trials Group
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
University of Wisconsin, Madison
Mayo Clinic
Roswell Park Cancer Institute
Roswell Park Cancer Institute
Barbara Ann Karmanos Cancer Institute
M.D. Anderson Cancer Center
Wake Forest University Health Sciences
Wake Forest University Health Sciences
University of California, San Francisco
Fred Hutchinson Cancer Center
Wake Forest University Health Sciences
Massachusetts General Hospital
Fred Hutchinson Cancer Center
Alliance for Clinical Trials in Oncology
Rutgers, The State University of New Jersey
Alliance for Clinical Trials in Oncology
City of Hope Medical Center
City of Hope Medical Center
Indiana University
City of Hope Medical Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
National Cancer Institute (NCI)
INSYS Therapeutics Inc
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Northside Hospital, Inc.
Rutgers, The State University of New Jersey
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
Vanderbilt-Ingram Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)